A Texas federal judge today extended a block on a federal rule that would require dialysis providers to disclose any charitable assistance patients receive to insurers. The indefinite extension was granted by U.S. District Judge Amos Mazzant in Sherman, Texas, in a suit filed by dialysis providers including Fresenius Medical Care (NYSE:FMS), DaVita. The rule, which was announced by […]
Outset Medical, previously Home Dialysis Plus, said it raised $91 million in a new funding round, with $51 million in equity and $40 million in debt funding. Funds are slated to continue development and promotion of its Tablo all-in-one dialysis system. The $51 million round of equity funding was led by new investor Fidelity Research […]
The fundraising continues at Minnesota’s Pursuit Vascular, which has reeled in more than $5.1 million through a new equity offering.
Executives disclosed the new cash infusion in a recent regulatory filing, though specific investors are not mentioned.
Pursuit Vascular said it raise approximately $1.6 million in a debt and securities offering to a group of 33 unnamed investors.
Based in Maple Grove, Minn., Pursuit markets a device called ClearGuard that’s designed to kill bacteria and fungi in hemodialysis catheters. The product, an antimicrobial fluid lock, received FDA approval in late 2013.